Publication | Closed Access

Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients

UrologyMedicinePolyglutamate ParotidPharmacologyPreliminary ResultsBenign Prostatic HyperplasiaProstatic DiseaseOncologyRadiation Oncology